MAT Act Signed Into Law, NABP Applauds Benefits for Overdose Prevention and Recovery Support
Shortly before the new year, President Joseph R. Biden signed the Consolidated Appropriations Act for 2023, which includes significant legislation to address the worsening overdose crisis. The National Association of Boards of Pharmacy® (NABP®) applauds the passage of the bill and its Mainstreaming Addiction Treatment Act (MAT Act) provision, which will remove federal barriers to […]
Read More ›NABP Joins Other Regulatory Associations In Launching Opioid Regulatory Collaborative
NABP and three other state board associations, have launched the Opioid Regulatory Collaborative (ORC). The ORC will bring together senior leaders from NABP, the American Association of Dental Boards, the Federation of State Medical Boards, and the National Council of State Boards of Nursing to share resources and strategies to slow opioid substance use disorder […]
Read More ›Medication Importation Requires More Study to Ensure Patient Safety, Cautions NABP
The National Association of Boards of Pharmacy® (NABP®) renewed its call to more carefully study the safety implications of allowing importation of prescription drugs from Canada after the Trump Administration announced plans to allow this activity. In a letter to its members, the state boards of pharmacy, NABP cautioned that allowing such practices places American patients at risk. […]
Read More ›White House Targets Drug Pricing, Importation Through Executive Action
Written by: Matthew Rubin and Libby Baney, Faegre Drinker Consulting The Trump Administration reignited its focus on prescription drug affordability and access last month through a series of executive orders targeting several longstanding priorities intended to drive costs down. On July 24, 2020, President Donald J. Trump signed four executive orders focused on cost, and […]
Read More ›NABP Urges Congressional Leaders to Continue Supporting Federal Programs to Combat Both Opioid Epidemic and COVID-19
Emphasizing the role that pharmacists and state boards of pharmacy play in protecting the public health, NABP has sent a letter to congressional leadership urging Congress to continue supporting robust investments in federal programs to combat both the ongoing opioid epidemic and coronavirus disease 2019 (COVID-19) pandemic. Signed by NABP Executive Director/Secretary Lemrey “Al” Carter, […]
Read More ›NABP Supports Boards of Pharmacy to Expedite Emergency Licensure for Pharmacists and Pharmacy Technicians
The National Association of Boards of Pharmacy® (NABP®) is assisting its member boards of pharmacy in expediting emergency and temporary licensure requests for licensed pharmacists and pharmacy technicians through its new program, NABP Passport. Developed in response to coronavirus disease 2019 (COVID-19), NABP Passport facilitates temporary authorization for pharmacists and pharmacy technicians to practice in […]
Read More ›U.S. Healthcare Licensing and Regulatory Organizations Issue Joint Statement on COVID-19 Pandemic
As the leading national organizations representing state and territorial health regulatory boards in the United States that regulate the practice of medicine, nursing, pharmacy, physical therapy, psychology, occupational therapy, and social work, we wish to express support for the many efforts being undertaken by our member boards and staff to enable health care providers and […]
Read More ›Interview With an Executive Director
Boards of pharmacy can face unexpected challenges while working to protect the public health. Here, board executive directors talk about how they worked around these obstacles. Jennifer Zaelit, BS, CPhT Bureau Manager, Division of Occupational and Professional Licensing, Utah Board of Pharmacy What is one of the most significant challenges or issues your board addressed […]
Read More ›Interview With a Board Executive Director
Boards of pharmacy can face unexpected challenges while working to protect the public health. Here, board executive directors talk about how they worked around these obstacles. Michael D. Bullek, BSP, RPh Administrator/Chief of Compliance, New Hampshire Board of Pharmacy What is one of the most significant challenges or issues your Board addressed in the past […]
Read More ›Interview With a Board Executive Director
Boards of pharmacy can face unexpected challenges while working to protect the public health. Here, board executive directors talk about how they worked around these obstacles. Marcie Bough, PharmD, RPh Executive Officer, Montana Board of Pharmacy What is one of the most significant challenges or issues your board addressed in the past year or so? […]
Read More ›